维普中文期刊产品整合服务
29篇 您的检索式:作者名="Mahaseth"
    题名 作者 年代 出处 被引量
1Circulating angiogenic cytokines in patients with advanced non-small cell lung cancer:correlation with treatment response and survival显示文摘Dudek AZ Mahaseth H 2005Cancer Invest2005,,3:1
2Bronchiolitis obliterans in chronic graft-versus-host disease:analysis of risk factors and treatment out- comes显示文摘Dudek AZ Mahaseth H DeFor TE 2003Biol Blood Man ow Transplant2003,,:1
3Bronchiolitis obliterans in chronicgraft-versus-host disease : analysis of risk factors and treatment outcomes显示文摘Dudek AZ Mahaseth H Defor TE 2003Biol Blood Marrow Transplant2003,9,10:1
4Bronchiolitis obliterans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomes显示文摘DUDEK A Z MAHASETH H DEFOR T E 2003Biol Blood Marrow Transplant2003,9,:1
5Bronchiolitis obliter- ans in chronic graft-versus-host disease: analysis of risk factors and treatment outcomes 显示文摘Dudek AZ Mahaseth H DeFor TE 2003Biol Blood Marrow Transplant2003,9,10:1
6Circulating angiogenic cytokines in patients with advanced non-small cell lung cancer:correlation with treatment response and survival显示文摘DUDEK A MAHASETH H 2005Cancer Investig2005,23,3:1
7Circulating angiogenic cytokines in patients with advanced non-small cell lung cancer: correlation with treatment response and survival显示文摘Dudek A Z Mahaseth H 2005Cancer Invest2005,23,3:1
8Circulating angiogenic cytokines in patients with advanced non-small cell lung cancer: correlation with treatment response and survival 显示文摘Dudek AZ Mahaseth H 2005Cancer Invest2005,23,3:1
9Heme oxygenase-1 is a modulator of inflammation and vaso-occlusion in transgenic sickle mice显示文摘Belcher1 JD Mahaseth H Welch TE 2006J Clin Invest2006,116,:1
10Modified FOLFIRINOX Regimen With Improved Safety and Maintained Efficacy in Pancreatic Adenocarcinoma显示文摘Hemchandra Mahaseth Edith Brutcher John Kauh Natalyn Hawk Sungjin Kim Zhengjia Chen David A. Kooby Shishir K. Maithel Jerome Landry Bassel F. El-Rayes 2013Pancreas2013,,8:1
11CircuLating angiogenic cytokines in patients with advanced non-small cell lung cancer: correlation with treatment response and survival显示文摘Dudek A Z Mahaseth H 2005Cancer lnvest2005,23,3:1
12Circulating angiogenic cytokines in patients with advanced non-small cell lung cancer: correlation with treatment response and survival 显示文摘I)udek A Z Mahaseth H 2005Cancer Invest2005,23,3:1
13Circulating angiogenic cytokines in patients with advanced non- small celt lung cancer, correlation with treatment response and survival显示文摘DUDEK A MAHASETH H 2005Cancer lnvestig2005,3,:1
14Circulating angiogenic cytokines in patients with advanced non-small cell lung cancer:correlation with treatment response and survival显示文摘Dudek AZ Mahaseth H 2005Cancer Invest2005,3,:1
15Circulating angiogenic cytokines in patients with advanced non-small cell lung cancer:correlation with treatment response and survival显示文摘Dudek AZ Mahaseth H 2005Cancer Invest2005,23,3:1
16Bronchiolitis oblite-rans in chronic graft-versus-host disease:analysis of risk factors and treatment outcomes显示文摘VDUDEK A Z MAHASETH H DEFOR T E 2003Bone Blood Marrow Transplant2003,9,10:1
17Circulating angiogenic cytokines in patients with advanced non-small cell lung cancer:correlation with treatment response and survival显示文摘Dudek AZ Mahaseth H 2005Cancer Invest2005,23,3:1
18Circulating angiogenic cytokines in patients with advanced non-small cell lung cancer:correlation with treatment response and survival显示文摘DUDEK A Z MAHASETH H 2005Cancer Invest2005,23,3:1
19Bronchiolitis obliterans in chronic graft - versus - host disease: Analysis of risk factors and treatment outcomes显示文摘Dudek AZ Mahaseth H DeFor TE 2003Biol Blood Marrow Transplant2003,9,10:1
20Bronchiolitis obliteransin chronicgraft-versus-host disease:analysis of risk factors and treatment outcomes显示文摘Dudek AZ Mahaseth H DeFor TE 2003Biol Blood Marrow Transplant2003,9,4:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费